IBU预处理方案行自体造血干细胞移植治疗急性髓系白血病10例的疗效

详细信息

收稿日期: 2014-10-23

Curative effect of IBU preconditioning regimen for autologous hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia

More Information

Received Date: 23 October 2014

[1]	张之南,沈悌.血液病诊断及疗效标准[M].3版.北京:科学出版社,2007:106-107.
[2]	Gratwohl A.Activity survey and historical perspective of autologous stem cell transplantation in Europe[J].Semin Hematol,2007,44:220-226.
[3]	Vellenga E,van Putten W,Ossenkoppele GJ,et al.Autologous peripheral blood stem cell transplantation for acute myeloid leukemia[J].Blood,2011,118:6037-6042.
[4]	Pfirrmann M,Ehninger G,Thiede C,et al.Prediction of post-remission survival in acute myeloid leukaemia:a post-hoc analysis of the AML96 trial[J].Lancet Oncol,2012,13:207-214.
[5]	Ferrara F,Palmieri S,Pedata M,et al.Autologous stem cell transplantation for elderly patients with acute myeloid leukaemia conditioned with continuous infusion idarubicin and busulphan[J].Hematol Oncol,2009,27:40-45.
[6]	Hong M,Miao KR,Zhang R,et al.High-dose idarubicin plus buslfan as conditioning regimen to autologous stem cell teansplantation:Promising post-remission therapy for acute myeloid leukemia in first complete remission?[J].Med Oncol,2014,31:980-984.